Bulut Gökten, D., & Mercan, R. (2026). Clinical Outcomes after Switching from Originator Infliximab to the Biosimilar Ixifi in Patients with Axial Spondyloarthritis: A Single-Center Study from Türkiye. Rheumatology (Bulgaria), 34(1), 4-20. https://doi.org/10.35465/wx09tq86